公司资料
Omnicell 股价、新闻与催化剂
- 股票代码:
- OMCL
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
36.03 USD (-3.40%)
收盘价
最后更新: 2026年8月17日
1.91B USD
市值
股价为何变动
As of Aug 17, 2026, OMCL closed down 3.40% at $36.03. No new same-company headline was identified in the current news window.
公司概览
业务概览
Omnicell is a healthcare technology company focused on medication-management automation and hospital workflow software.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Omnicell sits in healthcare IT and medtech infrastructure.
商业模式特征
Revenue comes from automation hardware, software, and recurring services used by hospitals and health systems.
生物医药行业定位
Omnicell is not a biotech stock, but it is important to the healthcare stack because it helps manage medication use and workflow.
未来催化剂
- Omnicell's catalysts are XT automation adoption, hospital medication-management software, and the pace of product-cycle upgrades. The business matters most when the installed base keeps expanding and recurring software gets more embedded.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。